A Single-Blind Randomized Controlled Study Comparing the Efficacy of High-Intensity Laser Therapy and Focused Extracorporeal Shock Wave Therapy in Patients With Plantar Fasciitis

Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-70
SponsorMahidol University

About this trial

This randomized controlled trial aims to evaluate the efficacy of High-Intensity Laser Therapy (HILT) and Focused Extracorporeal Shock Wave Therapy (fESWT) in reducing pain in patients with plantar fasciitis. The study also examines the effects of HILT and fESWT on health-related outcomes, including VAS-FA, FFI, plantar fascia thickness, and adverse events.

Researchers will compare HILT with fESWT as treatment options for patients with plantar fasciitis.

Participants will receive either HILT or fESWT along with an exercise program. They will attend follow-up visits to assess outcomes at 1, 2, 3, 6, and 12 weeks after the first treatment.

Eligibility criteria

Qualifiers

Patients aged 18-70 years

Pain was worse in the initial step after and an extended period of rest

Pain was decreased initially after the first steps but exacerbated with increased activity

VAS ≥ 4

Disqualifiers

Have Wound/Infection/tumor in treatment area

History of foot trauma in 3 months

History of intervention at plantar fascia in 6 months such as Ultrasound therapy, steroid injection, surgery or botulinum toxin injection

Pain medication within one week before participation

Trial design

Treatments tested in this trial

  • High power Laser therapy
  • Focused extracorporeal shock wave therapy

Treatment groups

28 Participants
are divided into 2 treatment groups

Locations

This trial has no locations

Sponsors and collaborators